Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
about
Toward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for womenOvarian tissue transport to expand access to fertility preservation: from animals to clinical practiceUpdate on primary ovarian insufficiencyFirst pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgeryLive imaging of follicle stimulating hormone receptors in gonads and bones using near infrared II fluorophore86 successful births and 9 ongoing pregnancies worldwide in women transplanted with frozen-thawed ovarian tissue: focus on birth and perinatal outcome in 40 of these children.Vitrification of human ovarian tissue: a practical and relevant alternative to slow freezingImpact of the cryopreservation technique and vascular bed on ovarian tissue transplantation in cynomolgus monkeys.Morphological, ultrastructural and functional imaging of frozen/thawed and vitrified/warmed human ovarian tissue retrieved from oncological patients.Follicular growth after xenotransplantation of cryopreserved/thawed human ovarian tissue in SCID mice: dynamics and molecular aspectsNew advances in ovarian autotransplantation to restore fertility in cancer patientsPrimary ovarian insufficiency: different approaches in three cases and a review of literatureIn Vitro Activation of Follicles and Fresh Tissue Auto-transplantation in Primary Ovarian Insufficiency Patients.Dysregulation of follicle development in a mouse model of premature ovarian insufficiency.Ovarian tissue cryopreservation and transplantation: scientific implications.Re-implantation of cryopreserved ovarian cortex resulting in restoration of ovarian function, natural conception and successful pregnancy after haematopoietic stem cell transplantation for Wilms tumour.Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood.Optimizing outcomes from ovarian tissue cryopreservation and transplantation; activation versus preservation.Recent advances in the field of ovarian tissue cryopreservation and opportunities for research.Good manufacturing practice requirements for the production of tissue vitrification and warming and recovery kits for clinical research.Activation of dormant follicles: a new treatment for premature ovarian failure?Female fertility preservation strategies: cryopreservation and ovarian tissue in vitro culture, current state of the art and future perspectives.The past, present and future of fertility preservation in cancer patients.Ovarian regeneration: The potential for stem cell contribution in the postnatal ovary to sustained endocrine function.Improving oocyte quality by transfer of autologous mitochondria from fully grown oocytes.Engineered endothelium provides angiogenic and paracrine stimulus to grafted human ovarian tissue.Vitrification versus slow freezing for human ovarian tissue cryopreservation: a systematic review and meta-anlaysis.Cryopreservation of human ovarian tissue using the silver closed vitrification system.Attempts to improve human ovarian transplantation outcomes of needle-immersed vitrification and slow-freezing by host and graft treatments.Presence of sucrose in the vitrification solution and exposure for longer periods of time improve post-warming follicle integrity in cat ovarian tissues.Ovarian injury during cryopreservation and transplantation in mice: a comparative study between cryoinjury and ischemic injury.Assessment of the effect of different vitrification solutions on human ovarian tissue after short-term xenotransplantation onto the chick embryo chorioallantoic membrane.Ovarian tissue cryopreservation using vitrification and/or in vitro activated technology.Effect of Exogenous Anti-Müllerian Hormone Treatment on Cryopreserved and Transplanted Mouse Ovaries.mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy.Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) pre-exposure ensures follicle integrity during in vitro culture of ovarian tissue but not during cryopreservation in the domestic cat model.Follicle activation is a significant and immediate cause of follicle loss after ovarian tissue transplantation.Premature Ovarian Insufficiency - an update on recent advances in understanding and management.An evaluation of the Gifu Model in a trial for a new regional oncofertility network in Japan, focusing on its necessity and effects.Advances in fertility preservation of female patients with hematological malignancies.
P2860
Q26771979-502D5610-DC6E-417F-AEE1-8100CD2B4A5CQ28073429-E33A98F9-2676-4409-AC32-DD7781CEB850Q28085503-B2E66FA5-C8D9-4685-B515-C77FB468B077Q30696847-042DE08A-245E-41DB-AEDF-3A7990BDD7DDQ33781591-111615A6-448A-4D94-88E4-05D7600FD6D6Q34548143-10701733-7293-4FE8-8A91-C7DA7F87C523Q35782321-A3F9FE27-A655-4AF2-9703-BCE0EA02EECEQ36010287-716CFDEB-D9B2-4732-AAC9-BFE68C1003C9Q36047474-A5E49F11-6CD7-4D12-A0C8-9EA96E568F2CQ36087872-99267341-F36C-43C0-81C0-5BBE717E53A6Q36490265-A72A5A24-2CED-466B-B3D9-83B2D580DEE4Q36955443-9F4F0325-CCBC-4C11-9561-4CC58C5C5424Q37393245-446AE152-65AB-4427-B2AA-6D9F8BDC16BCQ37417626-D3BC1416-2A53-45BC-A8AA-148FA8EC9301Q37519129-1CC633F2-F0BA-4719-B36C-D72A6DDF7F79Q37519135-E7CCE20A-7836-409D-9302-203316C02AA1Q38558604-B44D33D6-1B30-4A04-A489-74DD4476D7E9Q38582283-B1FB53D9-38ED-4A1E-B6E8-75C42BB4B2ACQ38736609-9FE17588-63F6-46EE-8136-FC9A1C708DD9Q38789138-243AAA98-ADF8-433A-86B5-72ED4EF109D2Q38792042-3BDCD695-FC01-4AC6-8853-F9F86E6F4714Q38824459-A580A29A-82E2-444A-AD02-36C68F6392A5Q38965305-A665EC70-229D-4EB2-9074-CBC94D5D702BQ38981589-D46B77D3-3D55-4861-BFD4-A7C45361B9C5Q39195570-7B91B088-3A61-4ED4-A712-1CE0B1A983DEQ41420811-48850E0E-234D-4196-B2A5-0A9BA21DF361Q41447744-2496F6CC-F96A-4970-8FC2-FE182510BD8AQ41596577-4CE9575A-9D1C-4937-86D5-FAFC73BF612BQ41597355-5E702C83-155E-42BD-99FB-04427227DCB4Q41598104-59AEFE12-1309-4B63-899B-BF43B5CBC908Q41598675-B4B5EAB1-D851-4886-A615-B7F9A68BCD5DQ41599304-18284CB9-7607-436C-A378-6CA8AEE125EAQ41600330-3D4B85EF-7EF3-472D-A3ED-66DD307FC59CQ41600554-305730AA-0127-46C2-972E-32F6DAD8062DQ41710033-E3D5C14B-A270-4830-8A27-58843A1D5253Q45350437-E862B6AC-3DA3-4FA4-BDCA-3D6639F18ED5Q46269665-89D78DED-FFB2-4A3B-AC90-8628822CC1AFQ47101603-CA07A07E-238E-42CA-A286-CE10A9D00BCAQ47124540-34EE7826-956D-44B3-9120-E1256C1D048CQ47662579-69DC48B0-8F4C-4325-9DDC-44857D02F194
P2860
Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Successful fertility preservat ...... primary ovarian insufficiency.
@en
Successful fertility preservat ...... primary ovarian insufficiency.
@nl
type
label
Successful fertility preservat ...... primary ovarian insufficiency.
@en
Successful fertility preservat ...... primary ovarian insufficiency.
@nl
prefLabel
Successful fertility preservat ...... primary ovarian insufficiency.
@en
Successful fertility preservat ...... primary ovarian insufficiency.
@nl
P2093
P2860
P356
P1433
P1476
Successful fertility preservat ...... primary ovarian insufficiency.
@en
P2093
Kazuhiro Kawamura
Midori Tamura
Nao Suzuki
Nobuhito Yoshioka
Seido Takae
Shu Hashimoto
Yoshiharu Morimoto
P2860
P304
P356
10.1093/HUMREP/DEU353
P407
P577
2015-01-06T00:00:00Z